Fulminant type 1 diabetes: nationwide effort to elucidate genetics, etiology, and pathogenesis since 2000
- PDF / 402,080 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 22 Downloads / 182 Views
COMMENTARY
Fulminant type 1 diabetes: nationwide effort to elucidate genetics, etiology, and pathogenesis since 2000 Hiroshi Ikegami1 · Akihisa Imagawa2 · Akira Shimada3 Received: 12 August 2020 / Published online: 29 September 2020 © The Japan Diabetes Society 2020
Since the first report on fulminant type 1 diabetes by Imagawa et al. in 2000 [1], Japanese research led by the Committee on Type 1 Diabetes, Japan Diabetes Society, has revealed the disease’s genetics, etiology, and pathogen‑ esis. As current chairpersons of the committee, we would like to take this opportunity to thank all the participants
and members actively involved in the nationwide studies orchestrated by the committee. We also thank the Japan Dia‑ betes Society for its continuous support and encouragement. The knowledge presented in this special issue could only be obtained with the shared effort of all these individuals and institutions.
Table 1 Studies on fulminant type 1 diabetes conducted by the Committee on Type 1 Diabetes, Japan Diabetes Society Committee chairpersons
Year Title
Journal
2000–2007 Makino H
2003 Fulminant type 1 diabetes: a nationwide survey in Japan 2005 Different contribution of class II HLA in fulminant and typi‑ cal autoimmune type 1 diabetes mellitus 2006 Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy 2007 Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy-a nationwide 5-year-study in Japan 2008 Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes 2008 Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus 2009 Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset 2010 Serum glycated albumin to haemoglobin A(1C) ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus
Diabetes Care 2003; 26:2345–52 Diabetologia 2005;48:294–300
2007–2012 Hanafusa T, Kobayashi T (co-chair)
* Hiroshi Ikegami [email protected] 1
Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, 377‑2 Ohno‑higashi, Osaka‑sayama, Osaka 589‑8511, Japan
13
Vol:.(1234567890)
J Clin Endocrinol Metab 2006; 91:471–6 Diabetologia 2007; 50:531–7 Diabetes Res Clin Pract 2008; 82:233–7 Ann Med 2008; 40:395–400
Diabetologia 2009; 52:2513–21 Ann Clin Biochem 2010; 47:313–7
2
Department of Internal Medicine (I), Osaka Medical College, 2‑7 Daigakucho, Takatsuki, Osaka 569‑8686, Japan
3
Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan
343
Fulminant type 1 diabetes: nationwide effort to elucidate genetics, etiology, and pathogenesis… Table 1 conutinued Committee chairpersons
Year Title
Journal
2012–2018 Hanafusa T, Kobayashi T (co-chair)
2012 Class II HLA genotype in fulminant type 1 diabetes: A
Data Loading...
